PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12172398-0	2002	Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil.	Gemfibrozil	124-135	peroxisome proliferator activated receptor alpha	Homo sapiens	18-28	
12172398-1	2002	PURPOSE: The effect of gemfibrozil is mediated by the activation of peroxisome proliferator-activated receptor alpha (PPAR alpha).	Gemfibrozil	23-34	peroxisome proliferator activated receptor alpha	Homo sapiens	68-116	
12172398-1	2002	PURPOSE: The effect of gemfibrozil is mediated by the activation of peroxisome proliferator-activated receptor alpha (PPAR alpha).	Gemfibrozil	23-34	peroxisome proliferator activated receptor alpha	Homo sapiens	118-128	
12172398-2	2002	The objective of this study was to determine whether the lipid response to gemfibrozil therapy is influenced by the PPAR alpha-L162V polymorphism.	Gemfibrozil	75-86	peroxisome proliferator activated receptor alpha	Homo sapiens	116-126	
12172398-5	2002	CONCLUSION: These results suggest that the HDL(2)-C response to gemfibrozil is modulated by the PPAR alpha-L162V polymorphism.	Gemfibrozil	64-75	peroxisome proliferator activated receptor alpha	Homo sapiens	96-106